You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
24 April 2026 - French pharmaceutical company Servier announced on Thursday the successful completion of its tender offer to acquire all of the issued and outstanding shares of common stock of Day One Biopharmaceuticals Inc (Nasdaq:DAWN), a US biopha...
24 April 2026 - Indian pharmaceutical company Cipla Limited (BSE:500087) (NSE:CIPLA-EQ) and its US subsidiary Cipla USA Inc announced on Thursday that the US Food and Drug Administration (FDA) has given final approval for the Abbreviated New Drug App...
24 April 2026 - Canadian pharmaceutical company Apotex Inc and Cumberland Pharmaceuticals Inc, a US-based specialty pharmaceutical company, announced on Thursday that they have entered into a strategic transaction to integrate Cumberland's US br...
23 April 2026 - Finnish pharmaceutical company Orion Corporation (Orion Pharma) (HEL:ORNBV) said on Thursday that it has initiated the TEADCO Phase 1b/2 basket trial evaluating ODM-212, an oral pan-TEAD inhibitor, in combination with standard-of-care...
23 April 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) and US biotechnology company Regeneron Pharmaceuticals Inc (Nasdaq:REGN) announced late Wednesday that the US Food and Drug Administration has approved Dupixent (...
23 April 2026 - Thryv Therapeutics Inc, a Canada-based, clinical-stage biotechnology company advancing novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for inherited cardiac arrhythmias, cardiometabolic diseases, and cardiomyopathies, ...